Glen Bolton

Glen Bolton is an Associate Vice President at Amgen, leading late-stage cell culture and purification development, as well as overseeing the Massachusetts pilot plant, with responsibility for a team of over 100 in Cambridge, MA, and Thousand Oaks, CA. Bolton's extensive experience includes roles as Executive Director and Director of Bioprocess Development at Amgen, Co-Founder of Zepteon, Inc., and a Senior Manager at Biogen Idec, where contributions included purification process development and regulatory document authorship for drugs such as ALPROLIX and ELOCTATE. Previous positions also include Assistant Adjunct Professor at Tufts University and Senior Principal Scientist at Pfizer/Wyeth, focusing on purification process development for various biotherapeutics. Education includes a PhD in Chemical Engineering from the Massachusetts Institute of Technology, along with degrees from MIT Sloan School of Management and UCLA.